ID   RGN_RAT                 Reviewed;         299 AA.
AC   Q03336; Q63496; Q925W3; Q9QWP2;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 3.
DT   18-JUN-2025, entry version 160.
DE   RecName: Full=Regucalcin;
DE            Short=RC;
DE   AltName: Full=Gluconolactonase;
DE            Short=GNL;
DE            EC=3.1.1.17;
DE   AltName: Full=Senescence marker protein 30;
DE            Short=SMP-30;
GN   Name=Rgn; Synonyms=Smp30;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=1420310; DOI=10.1016/0167-4781(92)90164-u;
RA   Fujita T., Shirasawa T., Uchida K., Maruyama N.;
RT   "Isolation of cDNA clone encoding rat senescence marker protein-30 (SMP30)
RT   and its tissue distribution.";
RL   Biochim. Biophys. Acta 1132:297-305(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=8348951; DOI=10.1016/0014-5793(93)80998-a;
RA   Shimokawa N., Yamaguchi M.;
RT   "Molecular cloning and sequencing of the cDNA coding for a calcium-binding
RT   protein regucalcin from rat liver.";
RL   FEBS Lett. 327:251-255(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Misawa H., Yamaguchi M.;
RT   "The gene family encoding the calcium-binding protein regucalcin.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-115.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=8979263; DOI=10.1007/bf00229476;
RA   Yamaguchi M., Makino R., Shimokawa N.;
RT   "The 5' end sequences and exon organization in rat regucalcin gene.";
RL   Mol. Cell. Biochem. 165:145-150(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 117-299.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=8569761; DOI=10.1007/bf01322338;
RA   Shimokawa N., Matsuda Y., Yamaguchi M.;
RT   "Genomic cloning and chromosomal assignment of rat regucalcin gene.";
RL   Mol. Cell. Biochem. 151:157-163(1995).
RN   [7]
RP   PROTEIN SEQUENCE OF 113-124, FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   PATHWAY, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RX   PubMed=16585534; DOI=10.1073/pnas.0511225103;
RA   Kondo Y., Inai Y., Sato Y., Handa S., Kubo S., Shimokado K., Goto S.,
RA   Nishikimi M., Maruyama N., Ishigami A.;
RT   "Senescence marker protein 30 functions as gluconolactonase in L-ascorbic
RT   acid biosynthesis, and its knockout mice are prone to scurvy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:5723-5728(2006).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=8794449; DOI=10.1016/0047-6374(96)01711-3;
RA   Fujita T., Shirasawa T., Uchida K., Maruyama N.;
RT   "Gene regulation of senescence marker protein-30 (SMP30): coordinated up-
RT   regulation with tissue maturation and gradual down-regulation with aging.";
RL   Mech. Ageing Dev. 87:219-229(1996).
RN   [9]
RP   FUNCTION, AND COFACTOR.
RX   PubMed=15251439; DOI=10.1016/j.febslet.2004.06.028;
RA   Kondo Y., Ishigami A., Kubo S., Handa S., Gomi K., Hirokawa K.,
RA   Kajiyama N., Chiba T., Shimokado K., Maruyama N.;
RT   "Senescence marker protein-30 is a unique enzyme that hydrolyzes
RT   diisopropyl phosphorofluoridate in the liver.";
RL   FEBS Lett. 570:57-62(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Gluconolactonase with low activity towards other sugar
CC       lactones, including gulonolactone and galactonolactone. Catalyzes a key
CC       step in ascorbic acid (vitamin C) biosynthesis. Can also hydrolyze
CC       diisopropyl phosphorofluoridate and phenylacetate (in vitro). Calcium-
CC       binding protein. Modulates Ca(2+) signaling, and Ca(2+)-dependent
CC       cellular processes and enzyme activities. {ECO:0000269|PubMed:15251439,
CC       ECO:0000269|PubMed:16585534, ECO:0000269|PubMed:8794449}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glucono-1,5-lactone + H2O = D-gluconate + H(+);
CC         Xref=Rhea:RHEA:10440, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16217, ChEBI:CHEBI:18391; EC=3.1.1.17;
CC         Evidence={ECO:0000269|PubMed:16585534};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:15251439, ECO:0000269|PubMed:16585534};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:15251439, ECO:0000269|PubMed:16585534};
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:15251439, ECO:0000269|PubMed:16585534};
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:15251439, ECO:0000269|PubMed:16585534};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:15251439, ECO:0000269|PubMed:16585534};
CC       Note=Binds 1 divalent metal cation per subunit. Most active with Zn(2+)
CC       and Mn(2+) ions. The physiological cofactor for gluconolactonase
CC       activity is most likely Ca(2+) or Mg(2+). Mg(2+), Mn(2+) and Co(2+) are
CC       equally efficient for the hydrolysis of diisopropyl
CC       phosphorofluoridate. {ECO:0000269|PubMed:15251439,
CC       ECO:0000269|PubMed:16585534};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=9.4 mM for gluconolactone {ECO:0000269|PubMed:16585534};
CC         Vmax=345 umol/min/mg enzyme {ECO:0000269|PubMed:16585534};
CC       pH dependence:
CC         Optimum pH is 6.4. {ECO:0000269|PubMed:16585534};
CC   -!- PATHWAY: Cofactor biosynthesis; L-ascorbate biosynthesis via UDP-alpha-
CC       D-glucuronate pathway; L-ascorbate from UDP-alpha-D-glucuronate: step
CC       3/4. {ECO:0000269|PubMed:16585534}.
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Detected in liver (at protein level). Hepatocytes
CC       and renal proximal tubular epithelium. {ECO:0000269|PubMed:1420310,
CC       ECO:0000269|PubMed:16585534, ECO:0000269|PubMed:8794449}.
CC   -!- DEVELOPMENTAL STAGE: In liver, the first peak of expression was found
CC       in 5-day-old neonates. Expression increases from day 7 and reaches a
CC       plateau at day 10. 3-6.5 moth-old adults express about a third the
CC       amount of neonates level. In kidney, expression increases from day 21
CC       and reaches a maximal level at day 35, remains high until 3 months of
CC       age.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- SIMILARITY: Belongs to the SMP-30/CGR1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X69021; CAA48786.1; -; mRNA.
DR   EMBL; D38467; BAA07490.1; -; mRNA.
DR   EMBL; AB037934; BAA90692.1; -; mRNA.
DR   EMBL; BC078794; AAH78794.1; -; mRNA.
DR   EMBL; D67070; BAA11083.1; -; Genomic_DNA.
DR   EMBL; D31662; BAA06507.1; -; Genomic_DNA.
DR   PIR; S34588; S34588.
DR   RefSeq; NP_113734.1; NM_031546.2.
DR   AlphaFoldDB; Q03336; -.
DR   SMR; Q03336; -.
DR   FunCoup; Q03336; 265.
DR   IntAct; Q03336; 2.
DR   STRING; 10116.ENSRNOP00000010984; -.
DR   iPTMnet; Q03336; -.
DR   PhosphoSitePlus; Q03336; -.
DR   PaxDb; 10116-ENSRNOP00000010984; -.
DR   Ensembl; ENSRNOT00000010984.6; ENSRNOP00000010984.4; ENSRNOG00000007949.6.
DR   GeneID; 25106; -.
DR   KEGG; rno:25106; -.
DR   UCSC; RGD:3560; rat.
DR   AGR; RGD:3560; -.
DR   CTD; 9104; -.
DR   RGD; 3560; Rgn.
DR   eggNOG; KOG4499; Eukaryota.
DR   GeneTree; ENSGT00390000014995; -.
DR   HOGENOM; CLU_036110_3_2_1; -.
DR   InParanoid; Q03336; -.
DR   OMA; WAGTMRY; -.
DR   OrthoDB; 423498at2759; -.
DR   PhylomeDB; Q03336; -.
DR   TreeFam; TF323663; -.
DR   BioCyc; MetaCyc:MONOMER-13233; -.
DR   BRENDA; 3.1.8.2; 5301.
DR   UniPathway; UPA00991; UER00938.
DR   PRO; PR:Q03336; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   Bgee; ENSRNOG00000007949; Expressed in liver and 16 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0030234; F:enzyme regulator activity; IEA:InterPro.
DR   GO; GO:0004341; F:gluconolactonase activity; IDA:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0019853; P:L-ascorbic acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0097421; P:liver regeneration; IEP:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:1903011; P:negative regulation of bone development; IDA:RGD.
DR   GO; GO:2000279; P:negative regulation of DNA biosynthetic process; IMP:RGD.
DR   GO; GO:1903625; P:negative regulation of DNA catabolic process; IDA:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:RGD.
DR   GO; GO:1901318; P:negative regulation of flagellated sperm motility; IDA:RGD.
DR   GO; GO:0010558; P:negative regulation of macromolecule biosynthetic process; IDA:RGD.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IMP:RGD.
DR   GO; GO:1902679; P:negative regulation of RNA biosynthetic process; IMP:RGD.
DR   GO; GO:0032781; P:positive regulation of ATP-dependent activity; IDA:UniProtKB.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; IDA:RGD.
DR   GO; GO:0010907; P:positive regulation of glucose metabolic process; IDA:RGD.
DR   GO; GO:1903052; P:positive regulation of proteolysis involved in protein catabolic process; IDA:RGD.
DR   GO; GO:0010867; P:positive regulation of triglyceride biosynthetic process; IDA:RGD.
DR   GO; GO:0050848; P:regulation of calcium-mediated signaling; IDA:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IDA:RGD.
DR   FunFam; 2.120.10.30:FF:000027; Regucalcin homologue; 1.
DR   Gene3D; 2.120.10.30; TolB, C-terminal domain; 1.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR008367; Regucalcin.
DR   InterPro; IPR013658; SGL.
DR   InterPro; IPR005511; SMP-30.
DR   PANTHER; PTHR10907; REGUCALCIN; 1.
DR   PANTHER; PTHR10907:SF54; REGUCALCIN; 1.
DR   Pfam; PF08450; SGL; 1.
DR   PRINTS; PR01791; REGUCALCIN.
DR   PRINTS; PR01790; SMP30FAMILY.
DR   SUPFAM; SSF63829; Calcium-dependent phosphotriesterase; 1.
PE   1: Evidence at protein level;
KW   Ascorbate biosynthesis; Calcium; Cytoplasm; Direct protein sequencing;
KW   Hydrolase; Metal-binding; Phosphoprotein; Reference proteome.
FT   CHAIN           1..299
FT                   /note="Regucalcin"
FT                   /id="PRO_0000173049"
FT   ACT_SITE        204
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         18
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000250"
FT   BINDING         101
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         103
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         121
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         154
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000250"
FT   BINDING         204
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         144
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64374"
FT   MOD_RES         244
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64374"
FT   MOD_RES         253
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64374"
FT   MOD_RES         268
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CONFLICT        148
FT                   /note="D -> N (in Ref. 2; BAA07490 and 6; BAA06507)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   299 AA;  33390 MW;  5D8F2D95FCA4EE35 CRC64;
     MSSIKIECVL RENYRCGESP VWEEASKCLL FVDIPSKTVC RWDSISNRVQ RVGVDAPVSS
     VALRQSGGYV ATIGTKFCAL NWEDQSVFIL AMVDEDKKNN RFNDGKVDPA GRYFAGTMAE
     ETAPAVLERH QGSLYSLFPD HSVKKYFDQV DISNGLDWSL DHKIFYYIDS LSYTVDAFDY
     DLPTGQISNR RTVYKMEKDE QIPDGMCIDV EGKLWVACYN GGRVIRLDPE TGKRLQTVKL
     PVDKTTSCCF GGKDYSEMYV TCARDGMSAE GLLRQPDAGN IFKITGLGVK GIAPYSYAG
//
